2020
DOI: 10.1186/s12883-020-01861-7
|View full text |Cite
|
Sign up to set email alerts
|

Detailed visual assessment of striatal dopaminergic depletion in patients with idiopathic normal pressure hydrocephalus: unremarkable or not?

Abstract: Background: Dopamine transporter (DAT) imaging may enable clinicians to discriminate idiopathic normal pressure hydrocephalus (iNPH) from other parkinsonian disorders. However, a specific pattern of dopaminergic loss in DAT imaging of iNPH patients remains to be further elucidated. Methods: In this preliminary study, 11 patients with iNPH in our hospital between March 2017 and February 2019 were finally enrolled. A diagnosis of iNPH was made according to the two established criteria. For visual analysis of DAT… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
8
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 21 publications
0
8
0
Order By: Relevance
“…We initially suspected the coexistence of PD; however, most symptoms disappeared after the ETV, LIAS was finally conducted as the primary pathophysiology. Although the exact reason for slightly decreased presynaptic dopamine transporter density remains unclear in this patient, this finding is commonly observed in patients with idiopathic NPH [5].…”
Section: Discussionmentioning
confidence: 84%
“…We initially suspected the coexistence of PD; however, most symptoms disappeared after the ETV, LIAS was finally conducted as the primary pathophysiology. Although the exact reason for slightly decreased presynaptic dopamine transporter density remains unclear in this patient, this finding is commonly observed in patients with idiopathic NPH [5].…”
Section: Discussionmentioning
confidence: 84%
“…7 DAT imaging studies also indicated that the caudate nucleus was affected more than the putamen in patients with iNPH. 7,8 Regarding comorbidities, Espay et al investigated the outcome 3 years after shunt surgery, and none of the 8 patients with iNPH who had additional neurological diseases had persistent improvement, whereas 10 (43.5%) of 23 patients without concomitant neurological diseases had persistent improvement. 4 In addition, a case with iNPH comorbid with progressive parkinsonism was found to have concomitant synucleinopathy with REM sleep behavior disorder (RBD) and decreased DAT binding in the striatum 3 years after shunt surgery.…”
Section: Discussionmentioning
confidence: 99%
“…In the shunt responsive iNPH patient neurodegenerative co-pathology seems to modify the clinical phenotype ( 17 ). Abnormal DaT imaging is proof of impaired dopaminergic function in the basal ganglia but is aetiologically non-specific and has also been described in iNPH ( 18 , 19 ). CSF tau species in PSP and CBD have yielded conflicting results ( 20 ), CSF RT-QuIC of alpha-synuclein in LBD and tau in PSP and CBD ( 21 ) may be more promising.…”
Section: Clinicalmentioning
confidence: 99%